Articles by Jill Wechsler - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Jill Wechsler

Jill Wechsler


Jill Wechsler is BioPharm International's Washington editor.

Articles
Manufacturing Issues Crucial to Combating Ebola
November 20, 2014

The United States government is ramping up support for formulation, production, and packaging of Ebola treatments.

Combination Products Challenge Biopharma Manufacturers
November 5, 2014

Most new injectable drugs and biologics are being designed as combination therapies, presenting difficult regulatory and production issues for manufacturers. FDA policies are encouraging this trend.

New Era for Generic Drugs
November 1, 2014

Manufacturers face regulatory overhaul, while brand-generic debates escalate over biosimilars and labeling changes.

Biopharma Manufacturers Respond to Ebola Crisis
October 1, 2014

Demand for new therapies and vaccines spotlights production challenges.

Data Integrity Key to GMP Compliance
September 1, 2014

FDA demands accurate manufacturing and test information to ensure product quality.

Suppliers Seek to Boost Single-Use Technology
August 21, 2014

Attendees at the Bio-Process Systems Alliance annual summit discuss the benefits of single-use technology in biopharmaceutical manufacturing.

Changes and Challenges for Generic Drugs
August 1, 2014

FDA seeks high quality applications and products to facilitate approvals and reduce safety and supply problems.

Industry Seeks Clearer Standards for Track and Trace
July 1, 2014

Stakeholders face challenges and benefits from a more secure pharmaceutical supply chain.

Supplier Audit Program Marks Progress
July 1, 2014

Supplier Audit Program Marks Progress

ADVERTISEMENT

ADVERTISEMENT

Click here